The positivity of CD4, CD8, and CD34 markers was associated with a low degree of aggressiveness of soft-tissue sarcomas, without invasion of the tumor margins, thus illustrating a better survival rate in these patients. This evidence concerns the gene CD34 and soft tissue sarcoma.